Dashboard
Manage Tickers

INMDInMode Ltd.

Nasdaq inmodemd.com


$ 17.00 $ -0.01 (-0.06 %)    

Friday, 13-Sep-2024 14:19:27 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 475.70 $ 2.27 (0.48 %)
DIA $ 415.34 $ 2.71 (0.66 %)
SPY $ 562.35 $ 2.08 (0.37 %)
TLT $ 100.57 $ 0.09 (0.09 %)
GLD $ 238.67 $ 1.08 (0.45 %)
$ 16.75
$ 17.01
$ 14.60 x 112
$ 17.01 x 200
$ 16.97 - $ 17.10
$ 15.39 - $ 36.34
1,067,166
na
1.41B
$ 1.89
$ 7.11
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

calavo-growers-posts-better-than-expected-earnings-joins-tesla-oracle-mission-produce-and-other-big-stocks-moving-higher-on-tuesday
Calavo Growers Posts Better-Than-Expected ...
09/10/2024 14:07:31

inmode-board-approves-share-repurchase-program-of-up-to-768m-ordinary-shares
InMode Board Approves Share Repurchase Pro...
09/10/2024 11:03:49

The Company's ordinary share repurchases, if any, will be funded with available cash. Share repurchases may be commenced, s...

Core News & Articles
CORRECTTION: InMed Ticker Is 'INM'
08/20/2024 11:38:18

inmode-q2-2024-adj-eps-046-beats-038-estimate-sales-102622m-miss-104762m-estimate
InMode Q2 2024 Adj. EPS $0.46 Beats $0.38 ...
08/01/2024 11:04:58

jefferies-downgrades-inmode-to-hold-lowers-price-target-to-19
Jefferies Downgrades InMode to Hold, Lower...
07/23/2024 10:39:42

Jefferies analyst Matthew Taylor downgrades InMode (NASDAQ:INMD) from Buy to Hold and lowers the price target from $21 to $19.

inmode-announces-morpheus8-fda-510k-clearance-for-soft-tissue-contraction-for-fractional-radiofrequency-microneedling
InMode Announces Morpheus8 FDA 510(k) Clea...
07/17/2024 12:05:25

barclays-maintains-overweight-on-inmode-lowers-price-target-to-29
Barclays Maintains Overweight on InMode, L...
07/15/2024 12:58:00

Barclays analyst Matt Miksic maintains InMode (NASDAQ:INMD) with a Overweight and lowers the price target from $33 to $29.

canaccord-genuity-maintains-hold-on-inmode-lowers-price-target-to-16
Canaccord Genuity Maintains Hold on InMode...
07/12/2024 14:12:54

Canaccord Genuity analyst Caitlin Cronin maintains InMode (NASDAQ:INMD) with a Hold and lowers the price target from $21 to ...

needham-reiterates-hold-on-inmode
Needham Reiterates Hold on InMode
07/11/2024 15:11:40

Needham analyst Mike Matson reiterates InMode (NASDAQ:INMD) with a Hold.

inmode-sees-q2-revenue-between-862m-863m-pro-forma-revenue-between-1024m-1025m-vs-11658m-est-decreases-fy-2024-guidance-to-430m-440m-vs-4795m-est
InMode Sees Q2 Revenue Between $86.2M-$86....
07/11/2024 13:21:32

Expects Q2 Revenue Between $86.2M-$86.3M, Pro-Forma Revenue (including new platform pre-orders) Between $102.4M-$102.5M, Decrea...

needham-reiterates-hold-on-inmode
Needham Reiterates Hold on InMode
05/03/2024 10:17:23

Needham analyst Mike Matson reiterates InMode (NASDAQ:INMD) with a Hold.

inmode-sees-fy24-adj-eps-of-201---205-vs-249-est
InMode Sees FY24 Adj EPS OF $2.01 - $2.05 ...
05/02/2024 11:16:24

inmode-cuts-fy24-revenue-guidance-from-495m--505m-to-485m---495m-vs-49325m-est
InMode Cuts FY24 Revenue Guidance From $49...
05/02/2024 11:15:21

inmode-q1-adj-032-misses-044-estimate-sales-8028m-miss-9302m-estimate
InMode Q1 Adj $0.32 Misses $0.44 Estimate,...
05/02/2024 11:02:41

InMode (NASDAQ:INMD) reported quarterly earnings of $0.32 per share which missed the analyst consensus estimate of $0.44 by 27....

inmode-defends-its-feminine-rejuvenation-patent-against-btl-industries-review-request
InMode Defends Its Feminine Rejuvenation P...
04/15/2024 11:08:08

InMode Ltd. (NASDAQ:INMD), a leading global provider of innovative medical technologies, responded to the recent petition to th...

barclays-maintains-overweight-on-inmode-lowers-price-target-to-33
Barclays Maintains Overweight on InMode, L...
04/12/2024 13:59:14

Barclays analyst Matt Miksic maintains InMode (NASDAQ:INMD) with a Overweight and lowers the price target from $34 to $33.

btl-petitions-uspto-to-cancel-all-58-claims-of-us-patent-no-8961511-owned-by-the-company-inmode-ltd
BTL Petitions USPTO To Cancel All 58 Claim...
04/11/2024 13:27:53

BTL Industries, Inc., a leading provider of innovative medical aesthetic solutions, petitioned the U.S. Patent Office to cancel...

why-tilray-brands-shares-are-trading-lower-by-around-22-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Tilray Brands Shares Are Trading Lower...
04/09/2024 17:12:29

Shares of Tilray Brands, Inc. (NASDAQ: TLRY) fell sharply during Tuesday’s session after the company missed third-quarter esti...

needham-reiterates-hold-on-inmode
Needham Reiterates Hold on InMode
04/09/2024 15:53:24

Needham analyst Mike Matson reiterates InMode (NASDAQ:INMD) with a Hold.

maxeon-solar-technologies-neogen-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session
Maxeon Solar Technologies, Neogen And Othe...
04/09/2024 11:42:21

U.S. stock futures were mixed this morning, with the Nasdaq futures gaining by around 0.2% on Tuesday. Shares of Maxeon Solar...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION